C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d: Numerous publications have underlined the link between complement C5a and the clinical course of… #immunology https://t.co/U7zMKqp
⬆️C5a in CP from severe COVID19 is not asso wth early complement activ markers C3bBbP or C4d: complement pathway fuels⬆️C5a in hosp & follow-up; alternative pathway (AP) activ marker C3bBbP & soluble fraction C4d,footprint of classical/lectin (CP/L
New Research: C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d: Numerous publications have underlined the link between complement C5a and the clinical course of… https://t.co/9PuZP